# Correction: Dual targeting multiwalled carbon nanotubes for improved neratinib delivery in breast cancer

**Authors:** Amr Selim Abu Lila, Rohini Bhattacharya, Afrasim Moin, Turki Al Hagbani, Marwa Helmy Abdallah, Syed Mohd Danish Rizvi, El-Sayed Khafagy, Talib Hussain, Hosahalli Veerabhadrappa Gangadharappa

PMC · DOI: 10.1039/d5ra90025e · RSC Advances · 2025-03-19

## TL;DR

This paper corrects a previous study on using carbon nanotubes to improve drug delivery for breast cancer treatment.

## Contribution

The correction addresses errors or omissions in the original study's methodology or findings.

## Key findings

- Errors in the original paper have been identified and corrected.
- The revised study maintains the focus on improving neratinib delivery using multiwalled carbon nanotubes.

## Abstract

Correction for ‘Dual targeting multiwalled carbon nanotubes for improved neratinib delivery in breast cancer’ by Amr Selim Abu Lila et al., RSC Adv., 2023, 13, 24309–24318, https://doi.org/10.1039/D3RA04732F.

## Linked entities

- **Chemicals:** neratinib (PubChem CID 9915743)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Diseases:** breast cancer (MESH:D001943)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11923591/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11923591/full.md

---
Source: https://tomesphere.com/paper/PMC11923591